CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Hisun Pharmaceutical Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Hisun Pharmaceutical Co., Ltd.
No. 46, Waisha Road, Jiaojiang District
Phone: +86 57185278141p:+86 57185278141 TAIZHOU, ZHJ  318000  China Ticker: 600267600267
Business Summary
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceuticals. The Company mainly operates three businesses. The pharmaceutical manufacturing business includes pharmaceutical preparations business, pharmaceutical active pharmaceutical ingredients business and animal medicine business. The pharmaceutical commercial business includes pharmaceutical distribution business, imported pharmaceutical preparations and drug marketing outsourcing business. The emerging business is engaged in research and development in the field of synthetic biology and other businesses. The Company's main products include anti-tumor drugs, anti-infective drugs, cardiovascular drugs, antiparasitic drugs, veterinary drugs, endocrine drugs and other drugs. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President WeihongXiao 56 10/10/2024 10/11/2023
Chief Financial Officer, Senior Vice President LingJiang 54 4/26/2024 4/25/2007
Senior Vice President, Director JiaqiuDu 51 4/19/2022 5/13/2019
8 additional Officers and Directors records available in full report.

Business Names
Business Name
600267
Zhejiang Hisun Pharmaceutical Co., Ltd.
ZHEJIANG HISUN PHARMACEUTICAL CO.,LTD

General Information
Number of Employees: 7,994 (As of 12/31/2024)
Outstanding Shares: 1,198,848,196 (As of 3/31/2025)
Shareholders: 53,191
Stock Exchange: SHA
Fax Number: +86 57688827887


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, June 3, 2025